OxySure Therapeutics, Inc. 5
5 · OxySure Therapeutics, Inc. · Filed Feb 16, 2016
Insider Transaction Report
Form 5
JONES JEREMY M
Director
Transactions
- Other
Common stock
2016-02-15$0.18/sh+50,000$9,250→ 182,474 total(indirect: By Trust)
Holdings
- 132,474(indirect: By Trust)
Common stock
- 181,818(indirect: By Trust)
Common stock
Footnotes (1)
- [F1]Acquired as an incentive for extending the due date of certain payment obligations by the Company.